Faculty profile

Nicole Mittmann

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses may be missing. Find their university profile.

Nicole Mittmann

Researcher

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
20 publications in the last five years, latest in 2026.
Senior (last) author on 3 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2022.
Supervised 1 trainee who won CIHR awards, most recently in 2009.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

121

Publications

1,347

Citations

h-index

174

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Drug Shortages Formulary Pharmaceuticals Supply Chain

Latest papers

Population-Level Resources and Costs Associated with Low-Risk Prostate Cancer Patients on Active Surveillance.
Cancers · 2026 · senior author
Using real-world, population-level data to assess the uptake of active surveillance for low-grade prostate cancer before and after the release of clinical guidelines
Journal of the Canadian Urological Association · 2025
Evaluating Real World Health System Resource Utilization and Costs for a Risk-Based Breast Cancer Screening Approach in the Canadian PERSPECTIVE Integration and Implementation Project.
Cancers · 2024

All 121 publications

Latest funding

Canadian Critical Care Trials Group COVID-19 Response: defining critical care capacity in Canada; testing treatments through large-scale adaptive clinical trials; & establishing the evidence base to inform clinical and health system management decisions
CIHR · 2022 · Co-investigator
$1,000,000
Canadian Critical Care Trials Group COVID-19 Response: defining critical care capacity in Canada; testing treatments through large-scale adaptive clinical trials; & establishing the evidence base to inform clinical and health system management decisions
CIHR · 2022 · Co-investigator
$4,000,000
Building solutions to address drugs shortages in Canada: developing an evidence-based at-risk medicine list
CIHR · 2022 · Principal investigator
$149,850

All 22 grants and awards

121 publications.

Population-Level Resources and Costs Associated with Low-Risk Prostate Cancer Patients on Active Surveillance.

Seung SJ, Bayani J, Nguyen L, Liu N, Gatley J, Wong A, Richard E, Barker SL, Lee AY, Bartlett JMS, Berman D, Loblaw A, Earle CC, Mittmann N

Cancers2026Senior author

DOI: 10.3390/cancers18101580 PMID: 42192940

Using real-world, population-level data to assess the uptake of active surveillance for low-grade prostate cancer before and after the release of clinical guidelines

Cheung DC, Martin LJ, Timilshina N, Komisarenko M, Richard PO, Alibhai SMH, Sussman J, Mittmann N, Finelli A

Journal of the Canadian Urological Association20251 citations

DOI: 10.5489/cuaj.9019

Evaluating Real World Health System Resource Utilization and Costs for a Risk-Based Breast Cancer Screening Approach in the Canadian PERSPECTIVE Integration and Implementation Project.

Seung SJ, Mittmann N, Ante Z, Liu N, Blackmore KM, Richard ES, Wong A, Walker MJ, Earle CC, Simard J, Chiarelli AM

Cancers2024

DOI: 10.3390/cancers16183189 PMID: 39335160

A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada.

Tan VS, Tjong MC, Chan WC, Yan M, Delibasic V, Darling G, Davis LE, Doherty M, Hallet J, Kidane B, Mahar A, Mittmann N, Parmar A, Tan H, Wright FC, Coburn NG, Louie AV

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2024

DOI: 10.1007/s00520-024-08584-2 PMID: 38787434

Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: a cost-consequence analysis using linked administrative data.

Hernando-Calvo A, Nguyen P, Bedard PL, Chan KKW, Saleh RR, Weymann D, Yu C, Amir E, Regier DA, Gyawali B, Kain D, Wilson B, Earle CC, Mittmann N, Abdul Razak AR, Isaranuwatchai W, Sabatini P, Spreafico A, Stockley TL, Pugh TJ, Williams C, Siu LL, Hanna TP

EClinicalMedicine2024

DOI: 10.1016/j.eclinm.2024.102443 PMID: 38380071

Development of a Canadian Guidance for reporting real-world evidence for regulatory and health-technology assessment (HTA) decision-making.

Tadrous M, Aves T, Fahim C, Riad J, Mittmann N, Prieto-Alhambra D, Rivera DR, Chan K, Lix LM, Kent S, Dawoud D, Guertin JR, McDonald JT, Round J, Klarenbach S, Stanojevic S, De Vera MA, Strumpf E, Platt RW, Husein F, Lambert L, Hayes KN

Journal of clinical epidemiology2024

DOI: 10.1016/j.jclinepi.2024.111545 PMID: 39322123

Changes in Health Care Costs, Survival, and Time Toxicity in the Era of Immunotherapy and Targeted Systemic Therapy for Melanoma.

Bateni SB, Nguyen P, Eskander A, Seung SJ, Mittmann N, Jalink M, Gupta A, Chan KKW, Look Hong NJ, Hanna TP

JAMA dermatology2023

DOI: 10.1001/jamadermatol.2023.3179 PMID: 37672282

Healthcare and Cancer Treatment Costs of Breast Screening Outcomes among Higher than Average Risk Women.

Mittmann N, Blackmore KM, Seung SJ, Diong C, Done SJ, Chiarelli AM

Current oncology (Toronto, Ont.)2023First author

DOI: 10.3390/curroncol30090620 PMID: 37754535

Hospital encounters and associated costs of prostate evaluation for clinically important disease MRI vs. standard evaluation procedures (PRECISE) study from a provincial-payer perspective.

Seung SJ, Saherawala H, Nguyen L, Gatley JM, Liu N, Kebabdjian M, Earle C, Klotz L, Mittmann N

Canadian Urological Association journal = Journal de l'Association des urologues du Canada2023Senior author

DOI: 10.5489/cuaj.8197 PMID: 37581543

Cost-effectiveness of second-line ipilimumab for metastatic melanoma: A real-world population-based cohort study of resource utilization.

Lu B, Dai WF, Croxford R, Isaranuwatchai W, Beca J, Menjak IB, Petrella TM, Mittmann N, Earle CC, Gavura S, Mercer RE, Hanna TP, Chan KKW

Cancer medicine2023

DOI: 10.1002/cam4.5862 PMID: 36999965

Something wrong or missing on this profile? Suggest a correction

Nicole Mittmann

Research

Latest papers

Latest funding

Population-Level Resources and Costs Associated with Low-Risk Prostate Cancer Patients on Active Surveillance.

Using real-world, population-level data to assess the uptake of active surveillance for low-grade prostate cancer before and after the release of clinical guidelines

Evaluating Real World Health System Resource Utilization and Costs for a Risk-Based Breast Cancer Screening Approach in the Canadian PERSPECTIVE Integration and Implementation Project.

A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada.

Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: a cost-consequence analysis using linked administrative data.

Development of a Canadian Guidance for reporting real-world evidence for regulatory and health-technology assessment (HTA) decision-making.

Changes in Health Care Costs, Survival, and Time Toxicity in the Era of Immunotherapy and Targeted Systemic Therapy for Melanoma.

Healthcare and Cancer Treatment Costs of Breast Screening Outcomes among Higher than Average Risk Women.

Hospital encounters and associated costs of prostate evaluation for clinically important disease MRI vs. standard evaluation procedures (PRECISE) study from a provincial-payer perspective.

Cost-effectiveness of second-line ipilimumab for metastatic melanoma: A real-world population-based cohort study of resource utilization.

Frequent collaborators

Ning Liu

Doris Howell

Geoffrey Liu

Wei Xu

Murray Krahn

Wanrudee Isaranuwatchai

Lehana Thabane

Keerat Grewal

William Evans

Lawson Eng

Sergio Rueda

Alexandra Papaioannou

Gordon Guyatt

Rinku Sutradhar

Julie Hallet

Jonathan Derrick Adachi

Lee Mozessohn

Andrew Loblaw

Nick Daneman

Nicole Mittmann

Jonathan Sussman

Lawrence Paszat

Jacques Simard

Ruxandra Pinto

Christina Ziebart

Gerard Morton

Ivy Cheng

Melanie Powis

Michael Yan

Derek Jonker

Eve Tsai

Jessie McGowan

Richard Van Der Jagt

Kelly Arbour-Nicitopoulos

Michael Schull

Tracy Stockley

Jason Garay

Julie Gilbert

Blair Henry

Winston Husbands